BIOJAM HOLDING GROUP and PASCOE Pharmazeutische Präparate GmbH, two European pharmaceutical companies, have recently announced a strengthening of their partnership in the European market.
BIOJAM, based in Portugal, and PASCOE, based in Germany, have chosen Gießen, where PASCOE is headquartered, as the location to strengthen their business collaboration. The partnership between the two companies aims to develop and market innovative pharmaceutical products to meet the needs of European patients in critical areas such as burn care, oncology, intensive care, and surgery. With this agreement, BIOJAM and PASCOE believe they will increase their presence in the market and provide patients with daily access to innovative and high-quality healthcare solutions.
